Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals | Small Cap
Health Score : 7.71Balaji Amines Ltd presents a mixed financial picture, characterized by exceptional stability but challenged by recent performance downturns. The company's key strengths lie in its fortress-like financial structure. It operates with virtually no debt, leading to outstanding solvency and coverage, meaning it can easily meet all its financial obligations. Profitability is also a standout, with the company demonstrating a superior ability to turn revenue into profit. However, these strengths are contrasted by significant weaknesses in growth and operational efficiency. Recent trends show a contraction in revenue and profits. Furthermore, the company is taking longer to sell its products and collect payments, indicating operational headwinds. In essence, Balaji Amines is a financially secure and highly profitable company facing a period of declining sales and operational sluggishness.
Health Score : 7.71Balaji Amines Ltd presents a mixed financial picture, characterized by exceptional stability but challenged by recent performance downturns. The company's key strengths lie in its fortress-like financial structure. It operates with virtually no debt, leading to outstanding solvency and coverage, meaning it can easily meet all its financial obligations. Profitability is also a standout, with the company demonstrating a superior ability to turn revenue into profit. However, these strengths are contrasted by significant weaknesses in growth and operational efficiency. Recent trends show a contraction in revenue and profits. Furthermore, the company is taking longer to sell its products and collect payments, indicating operational headwinds. In essence, Balaji Amines is a financially secure and highly profitable company facing a period of declining sales and operational sluggishness.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
47.17
Industry Median
39.73
Small Cap Median
37.95
P/E RATIO
46.70
P/B RATIO
3.95
Industry Median
2.59
Small Cap Median
2.40
P/S RATIO
5.48
Industry Median
2.52
Small Cap Median
2.34
Others
PEG RATIO
-6.89
EV/EBITDA RATIO
25.94
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹2409.7 as on Sep 1, 2026.
Growth Score : 2.80The company is currently in a phase of contraction, which is a major area of concern. Key metrics such as revenue, operating profit, and net income are all showing negative growth trends. While the company has continued to expand its asset base, this has not translated into improved financial performance. This divergence suggests that the company is facing significant headwinds in the market or internal challenges in converting its investments into profitable growth.
Revenue Growth RatePoorOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 76.91 | 1.38 | -30.48 | -14.84 | 2.59 |
| Operating Profit Growth Rate | 67.02 | -2.25 | -46.8 | -28.4 | 14.22 |
| Earnings Per Share (EPS) Growth | 54.69 | -11.64 | -37.08 | -23.09 | 6.13 |
| Asset Growth Rate | 33.21 | 12.49 | 9.32 | 4.94 | 21.8 |
| Net Income Growth Rate | 72.02 | -2.87 | -42.86 | -31.47 | 6.29 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | J.G.Chemicals Ltd | 9.23 | 37.26 | Neutral | 82.00 | 5.47 | 69.00 |
| 2 | Rossari Biotech Ltd | 8.46 | 17.69 | Neutral | 286.00 | 25.79 | 149.00 |
| 3 | Fineotex Chemical Ltd | 8.39 | 52.51 | Neutral | 135.00 | 0.79 | 125.00 |
| 4 | Vidhi Specialty Food Ingredients Ltd | 8.25 | 36.16 | Neutral | 78.00 | 9.84 | 49.00 |
| 5 | Bhansali Engineering Polymers Ltd | 8.25 | 17.56 | Undervalued | 216.00 | 7.25 | 180.00 |
| 6 | Styrenix Performance Materials Ltd | 8.12 | 19.35 | Neutral | 463.00 | 180.10 | 273.00 |
| 7 | Balaji Amines Ltd | 7.71 | 46.70 | Overvalued | 265.00 | 51.09 | 169.00 |
| 8 | Tatva Chintan Pharma Chem Ltd | 7.13 | 89.27 | Highly Overvalued | 93.00 | 16.71 | 42.00 |
| 9 | Neogen Chemicals Ltd | 6.69 | 197.61 | Highly Overvalued | 137.00 | 17.15 | 29.00 |
| 10 | Laxmi Organic Industries Ltd | 6.17 | 57.66 | Neutral | 171.00 | 2.86 | 79.00 |
| 11 | Yasho Industries Ltd | 6.09 | 203.81 | Neutral | 143.00 | 17.81 | 25.00 |
| 12 | Camlin Fine Sciences Ltd | 5.80 | 70.93 | Neutral | 107.00 | -1.72 | 24.00 |
| 13 | NOCIL Ltd | 5.27 | 50.94 | Neutral | 101.00 | 3.84 | 56.00 |
| 14 | Chemplast Sanmar Ltd | 4.81 | -9.62 | Neutral | 198.00 | -63.46 | -280.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Balaji Amines Ltd. is a leading Indian manufacturer of Aliphatic Amines, their derivatives, and Specialty Chemicals. Serving diverse industries like pharmaceuticals, agrochemicals, dyes, and water treatment, the company maintains a strong market position through backward integration, expanding product portfolio, and focus on niche chemical solutions.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Balaji Amines Ltd's P/E ratio (TTM) is 47.17, compared to the industry median of 39.73 and large cap median of 37.95.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Balaji Amines Ltd's P/B ratio is 3.95, compared to the industry median of 2.59 and large cap median of 2.40.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Balaji Amines Ltd's P/S ratio is 5.48, compared to the industry median of 2.52 and large cap median of 2.34.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Balaji Amines Ltd's PEG ratio is -6.89.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Balaji Amines Ltd's EV/EBITDA ratio is 25.94.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Balaji Amines Ltd's ROE is 8.55%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Balaji Amines Ltd's ROA is 9.66%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Balaji Amines Ltd's ROCE is 11%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Balaji Amines Ltd's operating margin is 18.60%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Balaji Amines Ltd's net margin is 11.86%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Balaji Amines Ltd's current ratio is 1.69.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Balaji Amines Ltd's debt-to-equity ratio is 0.03.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Balaji Amines Ltd's interest coverage ratio is 47.40.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Balaji Amines Ltd's DPS is ₹10.84.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Balaji Amines Ltd's EPS is 6.13.
(Source line: "Ratios as of 08 Oct 2026, based on last traded price of ₹2409.70. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1988
Headquarters: Pune, Maharashtra
Core Offerings: Methylamines, Ethylamines, Dimethyl Formamide (DMF), Specialty Chemicals, Pharmaceutical Excipients
Stock Listing: NSE (BALAMINES), BSE (530999)
Promoter: Reddy Group / A. Prathap Reddy
Founded in 1988, Balaji Amines Ltd. commenced commercial production in 1990 with Methylamines. The company steadily expanded its capacity and product range to include Ethylamines, Dimethyl Formamide, and various specialty chemicals. With a strategic focus on backward integration and diversification into high-value pharmaceutical excipients, it has established itself as a significant domestic manufacturer in the chemicals sector.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Amines & Specialty Chemicals | 100% | Consolidated financials reported, no separate segment-wise EBITDA available. |
Amines: Manufacturers of Methylamines (Mono, Di, Tri) and Ethylamines (Mono, Di, Tri), crucial intermediates for pharmaceuticals, agrochemicals, and rubber chemicals.
Dimethyl Formamide (DMF): A high-demand polar solvent widely used in chemicals, pharmaceuticals, and polyurethane industries.
Specialty Chemicals: Includes a range of derivatives of amines and other niche chemicals tailored for diverse industrial applications, enhancing product value.
Pharmaceutical Excipients: Producing specialized products like N-Methylpyrrolidone (NMP) derivatives and other intermediates essential for pharmaceutical formulations.
A. Prathap Reddy - Chairman & Managing Director. A visionary entrepreneur who founded the company, bringing over three decades of experience in the chemical industry. N. Rajeshwar Reddy - Joint Managing Director. With extensive experience in operations and strategic management, he plays a key role in driving the company's growth and efficiency.
Balaji Amines Speciality Chemicals Private Limited (BASPL) - Wholly owned subsidiary.
Balaji Power Private Limited (BPPL) - Operates a captive power plant.
Bonus Shares: 1:1 ratio in September 2021.
The Balaji Amines Ltd share price today is ₹2409.70 on NSE (BALAMINES), as of 08 Oct 2026.
As of 08 Oct 2026, Balaji Amines Ltd share price is ₹2409.70, with previous close ₹2409.70. Today's range is ₹2409.70 to ₹2409.70. The 52-week range is ₹N/A to ₹N/A.
As of today, Balaji Amines Ltd's market cap is ₹7,807.43 crore (Mid Cap).
Balaji Amines Ltd's current P/E ratio is 47.17, compared to the CHEMICALS & PETROCHEMICALS sector average of 34.50.
Balaji Amines Ltd's current P/B ratio is 3.95.
Balaji Amines Ltd's current dividend yield is 0.45%. Last dividend of ₹5.00 per share was declared on 28-May-2024.
Balaji Amines Ltd's EPS (TTM) is ₹6.13.
Balaji Amines Ltd. is a leading Indian manufacturer of Aliphatic Amines, their derivatives, and Specialty Chemicals. Serving diverse industries like pharmaceuticals, agrochemicals, dyes, and water treatment, the company maintains a strong market position through backward integration, expanding product portfolio, and focus on niche chemical solutions.
Balaji Amines Ltd is promoted by Reddy Group / A. Prathap Reddy, holding 54.59% as of 08 Oct 2026.
Balaji Amines Ltd is listed on NSE (BALAMINES) and BSE (530999). Its next quarterly results are expected on July/August 2024 (Q1 FY25).
Current Ratios